Transcriptomics

Dataset Information

0

Clonal Haematopoiesis-related Mutant ASXL1 Promotes Atherosclerosis in Mice via Dysregulated Innate Immunity [scRNA-seq]


ABSTRACT: Certain somatic mutations confer a fitness advantage in hematopoietic stem cells, resulting in the clonal expansion of mutant blood cells, known as clonal haematopoiesis (CH). Among the top 3 CH mutations, ASXL1 mutations present the highest risk for developing cardiovascular diseases (CVDs). However, how ASXL1 mutations induce CVDs remains totally elusive. Here we show that haematopoietic cells harbouring C-terminally truncated form of ASXL1 mutant (ASXL1-MT) accelerated development of atherosclerosis in Ldlr–/– mice. Transcriptome analyses of plaque-cells showed inflammatory signatures of monocytes and macrophages expressing ASXL1-MT. Mechanistically, wild-type ASXL1 inhibited innate immune signalling through the inhibition of IRAK1-TAK1 interaction in the cytoplasm, indicating an unexpected non-epigenetic role of ASXL1. In contrast, ASXL1-MT lost this regulatory function, leading to NF-κB activation. Intriguingly, IRAK1/4 inhibition decreased inflammatory monocytes and atherosclerosis driven by ASXL1-MT. The present work connects ASXL1 mutations with inflammation and CVDs, giving a clue to prevent CVDs in ASXL1-CH.

ORGANISM(S): Mus musculus

PROVIDER: GSE279601 | GEO | 2024/10/25

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-25 | GSE279450 | GEO
2021-02-08 | MSV000086816 | MassIVE
2021-12-02 | GSE150373 | GEO
2021-12-02 | GSE176036 | GEO
2018-06-01 | GSE99640 | GEO
2013-07-31 | GSE49118 | GEO
2013-07-31 | GSE49117 | GEO
2013-07-31 | E-GEOD-49118 | biostudies-arrayexpress
2013-07-31 | E-GEOD-49117 | biostudies-arrayexpress
| PRJNA1172723 | ENA